Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Title(s)
Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Dartmouth Cancer Center
Principal Investigator, SYNERGY, Dartmouth's Clinical and Translational Science Institute

Department(s)
The Dartmouth Institute
Medicine
Community and Family Medicine

Education
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Programs
Dartmouth Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice

Academic Analytics
View Profile

Contact Information

Geisel School of Medicine at Dartmouth
HB7505
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-646-5664
Email: Anna.Tosteson@dartmouth.edu

Assistant: Christopher Jacobs
Asst. Phone: 603-646-5237
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU


Professional Interests

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, electronic health record data, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis


Selected Publications

 

Relative timing of mammography and MRI for breast cancer screening: Impact on performance evaluation.
Lee JM, Ichikawa L, Kerlikowske K, Buist DSM, Lee CI, Sprague BL, Henderson LM, Onega T, Wernli KJ, Lowry KP, Stout NK, Tosteson ANA, Miglioretti DL
J Am Coll Radiol. 2024 Jul 3; pii: S1546-1440(24)00597-0. doi: 10.1016/j.jacr.2024.06.020. Epub 2024 Jul 3.
PMID: 38969253

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard BM, Hampton JM, Caswell-Jin JL, Gangnon RE, Lu Y, Huang H, Stein S, Sun L, Gil Quessep EJ, Yang Y, Lu Y, Song J, Muñoz DF, Li Y, Kurian AW, Kerlikowske K, O'Meara ES, Sprague BL, Tosteson ANA, Feuer EJ, Berry D, Plevritis SK, Huang X, de Koning HJ, van Ravesteyn NT, Lee SJ, Alagoz O, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS
JAMA. 2024 Jun 11;331(22):1947-1960. doi: 10.1001/jama.2023.24766.
PMID: 38687505

Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer.
Smith RE, Sprague BL, Henderson LM, Kerlikowske K, Miglioretti DL, Wernli KJ, Onega T, diFlorio-Alexander RM, Tosteson ANA
Breast Cancer Res. 2024 Apr 29;26(1):73. doi: 10.1186/s13058-024-01820-x. Epub 2024 Apr 29.
PMID: 38685119


Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard B, Hampton JM, Caswell-Jin J, Lu Y, Gangnon RE, Sun L, Huang H, Stein S, Quessep EG, Yang Y, Lu Y, Li Y, Song J, Muñoz DF, Kurian AW, Kerlikowske K, O’Meara ES, Sprague BL, Tosteson ANA, Berry D, Alagoz O, Plevritis SK, Huang X, de Koning H, van Ravesteyn N, Lee SJ, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS
. 2024 Apr;
PMID: 38718151

Predicting five-year interval second breast cancer risk in women with prior breast cancer.
Hubbard RA, Su YR, Bowles EJA, Ichikawa L, Kerlikowske K, Lowry KP, Miglioretti DL, Tosteson ANA, Wernli KJ, Lee JM
J Natl Cancer Inst. 2024 Jun 7;116(6):929-937. doi: 10.1093/jnci/djae063.
PMID: 38466940

Characterizing the Traveling Oncology Workforce and Its Influence on Patient Travel Burden: A Claims-Based Approach.
Scodari BT, Schaefer AP, Kapadia NS, O'Malley AJ, Brooks GA, Tosteson ANA, Onega T, Wang C, Wang F, Moen EL
JCO Oncol Pract. 2024 Jun;20(6):787-796. doi: 10.1200/OP.23.00690. Epub 2024 Feb 22.
PMID: 38386962

Response to Omoleye, Esserman, Olufunmilayo.
Kerlikowske K, Zhu W, Su YR, Sprague BL, O'Meara ES, Tosteson ANA, Wernli KJ, Miglioretti DL
J Natl Cancer Inst. 2024 Apr 5;116(4):629-630. doi: 10.1093/jnci/djae011.
PMID: 38230817

Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
Onega T, Garcia M, Beaber EF, Haas JS, Breslau ES, Tosteson ANA, Halm E, Chao CR, Barlow WE
J Gen Intern Med. 2024 Jun;39(8):1324-1331. doi: 10.1007/s11606-023-08562-0. Epub 2023 Dec 14.
PMID: 38097863

The Association of Rural Residence With Surgery and Adjuvant Radiation in Medicare Beneficiaries With Rectal Cancer.
Sha ST, Usadi B, Wang Q, Tomaino M, Brooks GA, Loehrer AP, Wong SL, Tosteson ANA, Colla CH, Kapadia NS
Adv Radiat Oncol. 2023 Nov-Dec;8(6):101286. doi: 10.1016/j.adro.2023.101286. Epub 2023 Jun 8.
PMID: 38047230

Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
Kerlikowske K, Zhu W, Su YR, Sprague BL, Stout NK, Onega T, O'Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL
J Natl Cancer Inst. 2024 Feb 8;116(2):249-257. doi: 10.1093/jnci/djad201.
PMID: 37897090

View more publications on PubMed